Allarity Therapeutics Stock Price

-0.02 (-1.12%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 41,883
Bid Price 1.20
Ask Price 2.19
News -
Day High 1.82


52 Week Range


Day Low 1.76
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Allarity Therapeutics Inc ALLR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.02 -1.12% 1.77 20:00:00
Open Price Low Price High Price Close Price Prev Close
1.82 1.76 1.82 1.77 1.79
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
318 41,883 $ 1.76 $ 73,814 - 1.10 - 17.45
Last Trade Time Type Quantity Stock Price Currency
17:55:15 1 $ 1.73 USD


Draw Mode:

Allarity Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 16.43M 9.28M 8.03M $ - $ - -4.19 -0.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 0.50%

more financials information »

Allarity Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ALLR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.781.871.741.8061,044-0.01-0.56%
1 Month2.623.381.542.42130,096-0.85-32.44%
3 Months2.123.381.102.38155,393-0.35-16.51%
6 Months12.0012.85761.103.19117,748-10.23-85.25%
1 Year13.1817.451.103.37117,383-11.41-86.57%
3 Years13.1817.451.103.37117,383-11.41-86.57%
5 Years13.1817.451.103.37117,383-11.41-86.57%

Allarity Therapeutics Description

Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improve clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.
Your Recent History
Allarity T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220628 05:50:06